Advertisement

Topics

Latest Cancer NewsRSS

02:31 EST 20th November 2017 | BioPortfolio

TRACON Pharmaceuticals Inc TCON Financial and Strategic SWOT Analysis Review [Report Updated: 13112017] Prices from USD $300

SummaryTRACON Pharmaceuticals Inc TRACON is a biopharmaceutical company that develops and commercializes targeted therapies for cancer, agerelated macular degeneration and fibrotic diseases. The company offers pipeline products such as TRC105, TRC102, TRC253, TRC694, and TRC205. Its lead product TRC105, is an antiendoglin antibody that is being developed for the treatment of multiple solid tumor t...

MDxhealth teams up with Pharmaceutical Company Ferrer for distribution of its Prostate Cancer test SelectMDx in Spain

Promising market with an estimate of over 300.000 Spanish men with elevated PSA levels MDxHealth's urine test  a non-invasive, molecular test clearly showing who could safely forego a painful biopsy, saving patients from over diagnosis and over treatment NEWS RELEASE / REGULATED INFORMATION /  INSIDE INFORMATION HERSTAL, BELGIUM and IRVINE, CA, - November 20,...

Patrys Ltd PAB Financial and Strategic SWOT Analysis Review [Report Updated: 13112017] Prices from USD $300

SummaryPatrys Ltd Patrys is a healthcare company that offers therapeutic products. The company develops natural human antibodybased therapeutic products for the treatment of cancer and many other diseases. Its product pipeline includes PATSC1 used for the treatment of gastric cancer; PATSM6, PATPA1, and PATLM1 used to treat multiple cancers. Patrys' pipeline consists of antibodies at different sta...

Phase III IMpower150 study showed Roche’s TECENTRIQ (atezolizumab) and Avastin (bevacizumab) plus chemotherapy significantly reduced the risk of disease worsening or death in the initial treatment of people with a type of advanced lung cancer

Roche today announced that the Phase III IMpower150 study met its co-primary endpoint of progression-free survival (PFS) and demonstrated that the combination of TECENTRIQ® (atezolizumab) and Avastin® (bevacizumab) plus chemotherapy (paclitaxel and carboplatin) provided a statistically significant and clinically meaningful reduction in the risk of disease worsening or death (PFS) compared to Ava...

Phase III IMpower150 Study Showed Genentech’s TECENTRIQ (atezolizumab) and Avastin (bevacizumab) Plus Chemotherapy Significantly Reduced the Risk of Disease Worsening or Death in the Initial Treatment of People with a Type of Advanced Lung Cancer

– Data will be submitted to health authorities globally, including the U.S. Food and Drug Administration (FDA) and European Medicines Agency (EMA) – Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), today announced that the Phase III IMpower150 study met its co-primary endpoint of progression-free survival (PFS) and dem...

Human Papillomavirus HPV Associated Cancer Pipeline Review, H2 2017 [Report Updated: 10102017] Prices from USD $2000

Human Papillomavirus HPV Associated Cancer Pipeline Review, H2 2017SummaryGlobal Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Human Papillomavirus HPV Associated Cancer Pipeline Review, H2 2017, provides an overview of the Human Papillomavirus HPV Associated Cancer Oncology pipeline landscape.Human papillomavirus HPV is the most common viral infection of the repro...

Veracyte Inc VCYT Financial and Strategic SWOT Analysis Review [Report Updated: 13112017] Prices from USD $300

SummaryVeracyte Inc Veracyte is a molecular diagnostics company that uses genomic technology to resolve diagnostic ambiguity. The company's pipeline products include Afirma thyroid FNA analysis for the diagnosis of thyroid cancer based on its proprietary afirma gene expression classifier. Its products also include percepta bronchial genomic classifier, an assay to evaluate patients with lung nodul...

Global and Regional Breast Implants Market Research Report 2017 [Report Updated: 25102017] Prices from USD $3500

SummaryBreast implants are medical devices that are implanted under the breast tissue or under the chest muscle to increase breast size augmentation or to rebuild breast tissue after mastectomy or other damage to the breast reconstruction. Breast implants are also used in revision surgeries, which correct or improve the result of an original surgery.Market Segment as follows:By Region AsiaPacif...

Samsung Bioepis Receives Regulatory Approval for Europe's First Trastuzumab Biosimilar, ONTRUZANT®

ONTRUZANT® is the industry’s first biosimilar referencing Herceptin® i (trastuzumab) to receive marketing authorization from the European Commission Samsung Bioepis sets an industry record by obtaining European regulatory approval for four biosimilars in just two years Samsung Bioepis Co., Ltd. today an...

Traumatic Brain Injury Market Insights, Epidemiology and Market Forecast 2025 [Report Updated: 10102017] Prices from USD $4600

DelveInsight's Traumatic Brain Injury Market Insights, Epidemiology and Market Forecast Market Insights, Epidemiology and Market Forecast 2025 report provides an overview of the disease and in depth research related to Traumatic Brain Injury Market Insights, Epidemiology and Market Forecast for the 7MM United States, Germany, France, Italy, Spain and UK for the study period undertaken from 201...

Verastem Inc VSTM Financial and Strategic SWOT Analysis Review [Report Updated: 13112017] Prices from USD $300

SummaryVerastem Inc Verastem is a biopharmaceutical company that discovers and develops drugs to treat cancer by the targeted killing of cancer stem cells. The company's products include VS6063, VS4718 and VS5584. Its VS6063 is used for the treatment of lung cancer, mesothelioma, and ovarian cancer. Verastem's VS4718 and VS5584 is used for the treatment of solid tumors and lymphomas. The company d...

VBL Therapeutics raising $18.75m in Nasdaq offering

The Israeli drug development company's lead product is a targeted anti-cancer gene-therapy agent to treat a wide range of solid tumors.

Cancer Patients, Survivors, Supporters and Caregivers Undertake UAE's First Relay for Life

Organised by Friends of Cancer Patients More than 2,000 ‘relayers’ take part in inaugural event held in United Arab Emirate Sharjah, the third largest of the United Arab Emirate’s seven emirates, was the host for the MENA region’s first ever ‘Global Relay for Life,’ (RFL) a 24-hour walkathon that is the biggest fundraising event fo...

XBiotech Inc XBIT Financial and Strategic SWOT Analysis Review [Report Updated: 13112017] Prices from USD $300

SummaryXBiotech Inc XBiotech is a bioscience company that discovers and develops True Human monoclonal antibodies the company provides monoclonal antibodies treatment for various diseases. It's lead product Xilonix, a therapeutic antibody being developed for the treatment of metastatic colorectal cancer. The company offers clinical trial activity services, oncology, MRSA, cardiovascular disease, d...

Diaxonhit SA ALEHT Medical Equipment Deals and Alliances Profile [Report Updated: 17102017] Prices from USD $250

SummaryDiaxonhit SA Diaxonhit, formerly ExonHit SA is a biotechnology company that provides diagnostic products. The company's products include TQS, which is used in treatment of teanus and BJI InoPlex, used for the treatment of prosthetic infection. It develops other diagnostic products using its molecular biology platform such as Dx15, a molecular diagnostic test for thyroid cancer.Diaxonhit ser...

IDL Biotech AB IDL B Financial and Strategic SWOT Analysis Review [Report Updated: 13112017] Prices from USD $300

SummaryIDL Biotech AB IDL Biotech is a healthcare products provider that develops, manufactures and markets vitro diagnostic tests. The company offers products in the clinical areas of oncology and bacteriology. It offers vitro diagnostic tumor activity markers for common types of cancer which include breast, colorectal, lung, ovarian and prostate cancer. IDL Biotech offers serum and urine analysi...

New York Jets And Bilal Powell Team Up With Colon Cancer Foundation To Help Raise Awareness And Save Lives

Running Back To Support Foundation Efforts Through Survivor Visits, Fundraising and Special In-Game Tribute NEW YORK (PRWEB) November 19, 2017 New York Jets running back Bilal Powell and the Colon Cancer Foundation® announced a new partnership aimed at defeating colon cancer and its devastating effects. Powell will help bring awareness to the disease, as well as generate funds in support of ...

Aethlon Medical Inc AEMD Medical Equipment Deals and Alliances Profile [Report Updated: 25102017] Prices from USD $250

SummaryAethlon Medical Inc Aethlon Medical is a developer of immunotherapeutic technologies for the treatment of infectious diseases and cancer. The company's lead product, Hemopurifier, strengthens natural immunity in human immunodeficiency virus and hepatitis C virus infected patients. Its other pipeline products include HER2osome, for combating HER2+ breast cancer; and ELLSA exosome assay, whic...

OncBioMune Pharmaceuticals Inc OBMP Financial and Strategic SWOT Analysis Review [Report Updated: 13112017] Prices from USD $300

SummaryOncBioMune Pharmaceuticals Inc OncBioMune, formerly Quint Media Inc is a biopharmaceutical company that develops novel cancer immunotherapy products. The company's products comprise biosimilars and vaccines developed for various cancer types such as breast, prostrate, renal and ovarian cancer. Its lead product ProscaVax, a therapeutic vaccine is developed for prostate cancer patients; and O...

Basilea Pharmaceutica Ltd BSLN Financial and Strategic SWOT Analysis Review [Report Updated: 13112017] Prices from USD $300

SummaryBasilea Pharmaceutica Ltd Basilea is a biopharmaceutical company that develops and markets antibiotics, antifungals and oncology drugs. The company's products address increasing resistance and nonresponse to present treatment options for various therapeutic areas such as cancer, bacterial infections and fungal infections, among others. Basilea also conducts research in the areas of antiinfe...

Colorectal Cancer Drug Development Pipeline Review, 2017 [Report Updated: 22092017] Prices from USD $3995

Colorectal Cancer Drug Development Pipeline Review, 2017SummaryThis report provides an overview of the colorectal cancer pipeline landscape. The report provides comprehensive information on the therapeutics under development and key players involved in therapeutic development for anal, rectal and colorectal cancer, and features dormant and discontinued projects.Anal cancer starts in the anus. Symp...

Raysearch Laboratories AB RAY B Financial and Strategic SWOT Analysis Review [Report Updated: 13112017] Prices from USD $300

SummaryRaySearch Laboratories AB RaySearch is a medical technology company that develops software solutions for radiation therapy of cancer. The company provides rayplan and raystation, a proprietary treatment planning system. It offers services such as installation, support, training and training schedule. RaySearch conducts research and development to ensure the long term development of new func...

New Data Show Benefit of Tagrisso in Patients with EGFR-mutated Non-small Cell Lung Cancer and Central Nervous System Metastases

Phase III FLAURA trial demonstrates 52% risk reduction of CNS disease progression or death in patients treated with Tagrisso (osimertinib) compared to current standard-of-care EGFR-TKIs* CAMBRIDGE, England–(BUSINESS WIRE)–AstraZeneca today presented new data from a subgroup analysis of the Phase III … Continue reading → Cet article

Guided Therapeutics Inc GTHP Financial and Strategic SWOT Analysis Review [Report Updated: 13112017] Prices from USD $300

SummaryGuided Therapeutics Inc GTI, formerly SpectRx Inc is a biotechnology company that offers platform technology for the early detection of disease that leads to cancer. The company provides products for the noninvasive cervical cancer detection markets. Its products include luviva advanced cervical scan and esophageal dysplasia detection system. GTI develops technology to painlessly detect dis...

Pancreatic Cancer Market Insights, Epidemiology and Market Forecast 2025 [Report Updated: 10102017] Prices from USD $4600

DelveInsight's Pancreatic Cancer Market Insights, Epidemiology and Market Forecast Market Insights, Epidemiology and Market Forecast 2025 report provides an overview of the disease and in depth research related to Pancreatic Cancer Market Insights, Epidemiology and Market Forecast for the 7MM United States, Germany, France, Italy, Spain and UK for the study period undertaken from 20152025.This...

Quick Search
Advertisement
 

review and buy Cancer market research data and corporate reports here